NCT01361386

Brief Summary

The purpose of this study is to describe the short-and long-tern (i.e. up to 2 years following the index event) AMPs in patients hospitalized for an acute coronary syndrome (i.e. STEMI or NSTE-ACS), and to document clinical outcomes, economic aspects and impact on quality of life of these AMPs in a 'real-life' setting.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13,011

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2011

Typical duration for all trials

Geographic Reach
7 countries

108 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 26, 2011

Completed
6 days until next milestone

Study Start

First participant enrolled

June 1, 2011

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
Last Updated

June 16, 2014

Status Verified

June 1, 2014

Enrollment Period

2.9 years

First QC Date

May 23, 2011

Last Update Submit

June 13, 2014

Conditions

Keywords

Long-term follow upAntithrombotic management patternsAcute Coronary SyndromeAsiaquality of life

Outcome Measures

Primary Outcomes (1)

  • short- and long-term medication and treatment prescribed by physicians in real-life setting

    up to 3 years

Secondary Outcomes (3)

  • clinical outcome (Cardiovascular events)

    up to 3 years

  • cost of hospitalization

    up to 3 years

  • quality of life (EQ-5D questionnaire)

    up to 3 years

Study Arms (1)

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Asian patients hospitalized for ACS within 48 hours of symptom onset and who have a final diagnosis of unstable angina (UA), STEMI or non-ST-segment elevation myocardial infarction (NSTEMI).

You may qualify if:

  • Written informed consent has been provided.
  • Diagnosis of STEMI, NSTEMI or UA
  • Hospitalization for the first time within 48 hours of onset of symptoms.

You may not qualify if:

  • UA, STEMI, NSTEMI precipitated by or as a complication of surgery, trauma, or GI bleeding or post-PCI UA, STEMI and NSTEMI occurring in patients already hospitalized for other reasons.
  • Current participation in a randomised interventional clinical trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (108)

Research Site

Hefei, Anhui, China

Location

Research Site

Wuhu, Anhui, China

Location

Research Site

Beijing, Beijing Municipality, China

Location

Research Site

Chongqing, Chongqing Municipality, China

Location

Research Site

Fuzhou, Fujian, China

Location

Research Site

Lanzhou, Gansu, China

Location

Research Site

Foshan, Guangdong, China

Location

Research Site

Guangzhou, Guangdong, China

Location

Research Site

Shenzhen, Guangdong, China

Location

Research Site

Nanning, Guangxi, China

Location

Research Site

Yulin, Guangxi, China

Location

Research Site

Guiyang, Guizhou, China

Location

Research Site

Baoding, Hebei, China

Location

Research Site

Shijiazhuang, Hebei, China

Location

Research Site

Tangshan, Hebei, China

Location

Research Site

Daqing, Heilongjiang, China

Location

Research Site

Harbin, Heilongjiang, China

Location

Research Site

Zhengzhou, Henan, China

Location

Research Site

Shiyan, Hubei, China

Location

Research Site

Wuhan, Hubei, China

Location

Research Site

Changsha, Hunan, China

Location

Research Site

Nanjing, Jiangsu, China

Location

Research Site

Wuxi, Jiangsu, China

Location

Research Site

Xuzhou, Jiangsu, China

Location

Research Site

Zhenjiang, Jiangsu, China

Location

Research Site

Changchun, Jilin, China

Location

Research Site

Jinzhou, Liaoning, China

Location

Research Site

Shenyang, Liaoning, China

Location

Research Site

Yingkou, Liaoning, China

Location

Research Site

Xining, Qinghai, China

Location

Research Site

Xi'an, Shaanxi, China

Location

Research Site

Jinan, Shandong, China

Location

Research Site

Shanghai, Shanghai Municipality, China

Location

Research Site

Changzhi, Shanxi, China

Location

Research Site

Jinzhong, Shanxi, China

Location

Research Site

Taiyuan, Shanxi, China

Location

Research Site

Chengdu, Sichuan, China

Location

Research Site

Tianjin, Tianjin Municipality, China

Location

Research Site

Shihezi, Xinjiang, China

Location

Research Site

Urumuqi, Xinjiang, China

Location

Research Site

Kunming, Yunnan, China

Location

Research Site

Hangzhou, Zhejiang, China

Location

Research Site

Hong Kong, China

Location

Research Site

Ningxia, China

Location

Research Site

Qingdao, China

Location

Research Site

Hyderabad, Andhra Pradesh, India

Location

Research Site

Guwahati, Assam, India

Location

Research Site

Ahmedabad, Gujarat, India

Location

Research Site

Surat, Gujarat, India

Location

Research Site

Vadodara, Gujarat, India

Location

Research Site

Gurgaon, Haryana, India

Location

Research Site

Bangalore, Karnataka, India

Location

Research Site

Manipal, Karnataka, India

Location

Research Site

Kochi, Kerala, India

Location

Research Site

Trivandrum, Kerala, India

Location

Research Site

Bhopal, Madhya Pradesh, India

Location

Research Site

Bilāspur, Madhya Pradesh, India

Location

Research Site

Aurangabad, Maharashtra, India

Location

Research Site

Mumbai, Maharashtra, India

Location

Research Site

Nagpur, Maharashtra, India

Location

Research Site

Pune, Maharashtra, India

Location

Research Site

Delhi, National Capital Territory of Delhi, India

Location

Research Site

Ludhiana, Punjab, India

Location

Research Site

Mohali, Punjab, India

Location

Research Site

Ajmer, Rajasthan, India

Location

Research Site

Jaipur, Rajasthan, India

Location

Research Site

Chennai, Tamil Nadu, India

Location

Research Site

Coimbatore, Tamil Nadu, India

Location

Research Site

Madurai, Tamil Nadu, India

Location

Research Site

Lucknow, Uttar Pradesh, India

Location

Research Site

Kolkata, West Bengal, India

Location

Research Site

Sarawak, Kuching, Malaysia

Location

Research Site

George Town, Malaysia

Location

Research Site

Singapore, Singapore

Location

Research Site

Busan, Busan, South Korea

Location

Research Site

Chuncheon, Chuncheon, South Korea

Location

Research Site

Cheonan, Chungcheongnam-do, South Korea

Location

Research Site

Deagu, Deagu, South Korea

Location

Research Site

Gwangju, Gwangju, South Korea

Location

Research Site

Bucheon-si, Gyeonggi-do, South Korea

Location

Research Site

Goyang-si, Gyeonggi-do, South Korea

Location

Research Site

Suwon, Gyeonggi-do, South Korea

Location

Research Site

Yangsan, Gyeongsangnam-do, South Korea

Location

Research Site

Jeju City, Jeju-do, South Korea

Location

Research Site

Iksan, Jeollabuk-do, South Korea

Location

Research Site

Seoul, Seoul, South Korea

Location

Research Site

Bangkoknoi, Bangkok, Thailand

Location

Research Site

Huaykwang, Bangkok, Thailand

Location

Research Site

PathumWan, Bangkok, Thailand

Location

Research Site

Payathai, Bangkok, Thailand

Location

Research Site

Rachathevi, Bangkok, Thailand

Location

Research Site

Saimai, Bangkok, Thailand

Location

Research Site

Muang, Changwat Chanthaburi, Thailand

Location

Research Site

Muang, Changwat Chon Buri, Thailand

Location

Research Site

Muang, Changwat Lampang, Thailand

Location

Research Site

Muang, Changwat Nan, Thailand

Location

Research Site

Klongluang, Changwat Pathum Thani, Thailand

Location

Research Site

Muang, Changwat Phitsanulok, Thailand

Location

Research Site

Muang, Changwat Songkhla, Thailand

Location

Research Site

Muang, Changwat Suphan Buri, Thailand

Location

Research Site

Muang, Changwat Surat Thani, Thailand

Location

Research Site

Muang, Chiangmai, Thailand

Location

Research Site

Muang, Chiangrai, Thailand

Location

Research Site

Muang, Khonkaen, Thailand

Location

Research Site

Muang, Nakornratchaseema, Thailand

Location

Research Site

Muang, Udonthani, Thailand

Location

Research Site

Ho Chi Minh City, Ho Chi Minh City, Vietnam

Location

Research Site

Huế, Hue, Vietnam

Location

Related Publications (4)

  • Huo Y, Van de Werf F, Han Y, Rossello X, Pocock SJ, Chin CT, Lee SW, Li Y, Jiang J, Vega AM, Medina J, Bueno H. Long-Term Antithrombotic Therapy and Clinical Outcomes in Patients with Acute Coronary Syndrome and Renal Impairment: Insights from EPICOR and EPICOR Asia. Am J Cardiovasc Drugs. 2021 Jul;21(4):471-482. doi: 10.1007/s40256-020-00447-5. Epub 2021 Feb 4.

  • Guan S, Xu X, Li Y, Li J, Guan M, Wang X, Jing Q, Huo Y, Han Y. Impact of Diabetes Mellitus on Antithrombotic Management Patterns and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndrome: Insights From the EPICOR Asia Study. J Am Heart Assoc. 2020 Nov 17;9(22):e013476. doi: 10.1161/JAHA.119.013476. Epub 2020 Nov 7.

  • Zhang S, Wang W, Sawhney JPS, Krittayaphong R, Kim HS, Nhan VT, Lee SW, Ong TK, Chin CT, Pocock SJ, Huo Y, Qian J, Ge J. Antithrombotic management and long-term outcomes following percutaneous coronary intervention for acute coronary syndrome in Asia. Int J Cardiol. 2020 Jul 1;310:16-22. doi: 10.1016/j.ijcard.2020.01.008. Epub 2020 Mar 17.

  • Jan S, Lee SW, Sawhney JPS, Ong TK, Chin CT, Kim HS, Krittayaphong R, Nhan VT, Pocock SJ, Vega AM, Hayashi N, Huo Y. Predictors of high-cost hospitalization in the treatment of acute coronary syndrome in Asia: findings from EPICOR Asia. BMC Cardiovasc Disord. 2018 Jul 4;18(1):139. doi: 10.1186/s12872-018-0859-4.

MeSH Terms

Conditions

Acute Coronary Syndrome

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Officials

  • Guy Yeoman

    AstraZeneca

    STUDY DIRECTOR
  • Prof. Huo Yong

    Peking University 1st Hospital

    STUDY CHAIR
  • Jayanti Visvanathan

    AstraZeneca

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2011

First Posted

May 26, 2011

Study Start

June 1, 2011

Primary Completion

May 1, 2014

Study Completion

May 1, 2014

Last Updated

June 16, 2014

Record last verified: 2014-06

Locations